Nasal Ryaltris® spray – the first product companies Glenmark

The consolidated sales Glenmark in the III quarter of 2020/2021 fiscal years grew by 3,88%

Завод в Оболенске начнет выпускать препарат от коронавируса «Фавипиравир»

Pfizer, Inc and BioNTech will increase capacities for productions vaccines from Koronavirus

" groups" Favipiravir for treatment of Koronavirus] plans to let out Binnofar

Company Glenmark again was included in an index of stability of the Dow Jones for emerging markets

Доход Glenmark по результатам II квартала 2020–2021 финансового года вырос на 4,88%

На индийском фармрынке появился доступный препарат для лечения легочного фиброза

Six Indian pharmaceutical companies will create the large center in Mexico

To be protected and watch gait. Clinical pharmacologists estimated advantage and harm of a preparation from Koronavirus

It is expensive and without guarantee: than treat Koronavirus to Russian Federation and the world

The first volunteer testing a vaccine from LLC "Vektor", received an inoculation